• The global market for continuous glucose monitoring devices and diabetes-related products totaled nearly $12.1 billion in 2016. The market should reach nearly $12.8 billion in 2017 and $20.7 billion in 2022, registering a compound annual growth (CAGR) of 10.1% from 2017-2022. • Blood glucose meters is the largest segment of the global market for continuous glucose monitoring products which will grow from $6.5 billion in 2017 to $7.6 billion by 2022 at a 3.2% CAGR for the period 2017-2022. • Insulin patch pumps as a segment will grow from $1.1 billion in 2017 to nearly $4.8 billion in 2022, increasing at a CAGR of 33.5% from 2017-2022.
Chapter 1: Introduction
Study Goals and Objectives This report HLC102C: Continuous Glucose Monitoring: Technologies and Global Markets provides an overview of the current and potential global market for monitoring equipment and disposables for both continuous monitoring and self–monitoring blood glucose (SMBG) equipment, which continues to be the standard method for monitoring blood glucose levels. The report provides comprehensive information on the causes of Type 1, Type 2 and gestational diabetes, highlighting global incidence and prevalence of the disease.
The key objective of the report is to present a comprehensive analysis of the current state of continuous glucose monitoring technology, important trends in the field, and relevant clinical trials and results. A second objective is to present sales forecasts for continuous glucose monitoring transmitters, receivers and sensors, insulin patch pumps and insulin durable or tubed pumps, SMGB glucose meters and diabetes test strips, for the period from 2016 through 2022. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the glucose monitoring market.
Revenue values are reported at the manufacturer level of the supply chain, and do not include any third party or distributor mark–ups. The report also addresses opportunities for future players. This report specifically does not address markets for devices for inhaling insulin, nor does it address markets for diabetes management software applications. Most of the larger companies that have come out with CGMs have also developed or acquired software for managing the individual’s diabetes, but the markets for these apps are not included in this report.
Reasons for Doing This Study This study was conducted to provide detailed information regarding developments in continuous glucose monitoring. The incidence of Type 2 diabetes continues to increase in developed and developing countries, driven by the rise in obesity.
Continuous glucose monitoring (CGM) is designed to provide a more accurate way to monitor blood glucose levels, thereby allowing diabetic patients to better regulate blood glucose, decrease the risk of diabetes–related damage to their bodies and ultimately improve their health and decrease healthcare costs.
This BCC Research market research report will increase the awareness of current and developing technologies affecting continuous glucose monitoring devices and markets.
Scope of Report The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self–monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device. Calibration may be required once or twice a day, or even less often, as the devices improve in the near future.
Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose. The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.
Information Sources Numerous companies within the industry were surveyed to obtain data for this study. These included manufacturers and end users of products, such as the medical device industry and research institutes. Data were gathered from various industry sources. BCC Research spoke with officials within the industry and consulted newsletters, company literature and product literature, as well as various technical articles, journals, indices and abstracts. Exhaustive investigations of databases by key terminology were completed. Data were also compiled from current financial, trade and government sources.
Methodology This report is the result of pulling together and analyzing information from a wide variety of sources. These sources include interviews with company managers, company reports, reports from international associations such as the International Diabetes Federation, among others. The gathered information was then compared and contrasted with other information sources, and forecasts made based upon the numbers obtained. Estimated growth rates have been created and justified based upon the analysis of the information.
In this report, the geographic regions considered for market analysis include, and only include: - North America. United States. o Canada.
- Europe. - Asia. - Rest of World.
Continuous Glucose Monitoring and Related Equipment, by Type CGM - Transmitters and Receivers - Sensors
Self–Monitoring Blood Glucose Equipment - SMBG meters - Test Strips
Continuous Glucose Monitoring, by Disease Type Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Other Diabetes
Continuous Glucose Monitoring, by Region USA Canada Europe Asia Rest of World
Continuous Glucose Monitoring, by Ages Children Teenagers Youth Middle–aged Aged
Continuous Glucose Monitoring, by Location of Use Home Setting Clinic Hospital
Chapter 2: Summary and Highlights Glucose monitoring is key to tracking glucose metabolic disturbance, evaluating therapies and guiding further treatment. However, blood glucose levels vary with time. Finger sticks and self–monitoring of blood glucose levels only capture data at points in time, and cannot display continuous glucose readings. Continuous glucose monitoring (CGM) was a dream that became reality in 1999 with the introduction of the first CGM device. Since then, companies have worked to improve the performance of the glucose sensors and the algorithms used to analyze and display the data.
The market for continuous glucose monitoring (CGM) products (defined as transmitters, receivers, and glucose sensors) used with these systems is growing at a strong rate as diabetics, physicians, hospitals and clinics come to realize that the use of CGMs provides significant assistance in the management of blood glucose levels, and as insurance plans move to reimburse for use of these devices.
The market is strong and growing in double digits. (Note: for purposes of splitting and forecasting the insulin patch and durable pumps, pumps are no longer included in the CGM total. The stand–alone CGM is likely to dominate the market in the future, but for this report, BCC Research has parsed CGM, insulin pumps, and transmitters and sensors into separate segments.)
The total CGM market, which consists of transmitters, receivers, and glucose sensors, was estimated to be worth $732 million in 2016. Due to the increasing amount of clinical evidence showing the efficacy of CGM in decreasing the number of hypoglycemic episodes, improvements in reimbursement for CGM, and the growth in the global number of people with diabetes (growth primarily seen in Type 2 diabetes [T2D] rather than Type 1 diabetes [T1D]), the total CGM market is forecast to reach a value of nearly $2.7 billion in 2022. The overall compound annual growth rate (CAGR) for this market from 2017 through 2022 is expected to be approximately 25.4%.
In 2016, in revenue terms, the transmitter and receiver sector represented about REDACTED of the CGM market, while glucose sensors represented about REDACTED. These percentages will basically stay the samethrough the forecast period. Sensors represent the larger of the two markets because sensors should (with current technology) be replaced at least every seven days. However, users tend to replace sensorsonly when they are ready to fall off, and therefore the market is smaller than would be expected if thedevices were replaced as per the instructions.
Our reports have been used by over 10K customers, including:
Artificial Pancreas Device System Market Research Report by Device Type (Control-to-Range System, Control-to-Target System, and Threshold Suspended Device System), by Treatment Type (Bi-hormonal, Hybrid, and Insulin Only), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Artificial Pancreas...
The diabetes care devices (BRIC) market is projected to grow at a CAGR of 16.2% The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. The growth in this market is primarily attributed to the sharp increase in...
The Continuous Glucose Monitoring (CGM) Market is anticipated to register a CAGR of 14.43% during the forecast period. As per WHO data, approximately half of all mortality can be associated with high blood glucose levels, which occur before the age of 70 years. WHO also expects diabetes to be the seventh-leading cause of mortality by 2030....
Blood Glucose Test Strips Market Research Report by Technology (Channel Technology and Wicking Technology), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Blood Glucose Test Strips Market is expected to grow...
215 pages •
By Global Industry Analysts
• Jul 2020
Global Diabetes Diagnostics Market to Reach $39.1 Billion by 2027 Amid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$26.3 Billion in the year 2020, is projected to reach a revised size of US$39.1 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Test Strips, one of the...
United States Diabetes Market, By Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast Diabetes is rising at an alarming rate in the United States. Diabetes referred to as diabetes mellitus, is a group of metabolic...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Syringe and Needle Market Report The syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019–2025. The global syringe and needle market constitutes an essential segment of the global medical devices...
KEY FINDINGS The global glucose monitoring system CGMS market is anticipated to grow at a CAGR of 22.31%, and the SMBG market is estimated to grow at 5.22% over the forecast period of 2019-2028. The various factors stimulating global market growth are surge in diabetes incidences, rise in healthcare expenditure, growing...
The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027. Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously.Several pharmaceutical and medical...
The Global Continuous Glucose Monitoring Device Market size is expected to reach $8.5 billion by 2026, rising at a market growth of 12.4% CAGR during the forecast period. Continuous Glucose Monitoring (CGM) is one of the newest advances in diabetes management technology. CGM system is a kind of glucose monitoring device that uses the transcutaneous...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.